Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer
Clinical trial NCT03989362 · COMPLETED
Trial details
- NCT number
- NCT03989362
- Sponsor
- Jounce Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2022-03-15
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.